KLK8 and diabetic cardiomyopathy: The present study identified KLK8-mediated plakoglobin nuclear translocation as a new modulator of p53-mediated induction of the TGF-β1 signaling pathway, which is able to promote the EndMT process in the context of diabetic cardiomyopathy.